Notes from the Editor: CCDR Volume 39-3, December 20, 2013

Notes from the Editor

Holiday Reflections

As we say good bye to 2013, we would like to highlight that this year marked the start of the revitalization of Canada Communicable Disease Report (CCDR). Volume 39 of the CCDR included 2 issues and five Advisory Committee Statements. From all of us in the Editorial Office, we extend our thanks to the Editorial Board, the many people within the Agency who have supported the journal, our contributors, peer reviewers and readers. We wish you a wonderful holiday season and all the best for 2014.

Index 2013

• ACS - 1, February 2013, Update on the Use of Quadrivalent Conjugate Meningococcal Vaccines
• ACS - 2, March 2013, Statement for Travellers and Yellow Fever
• ACS - 3, September 2013, Guidelines for the Prevention and Control of Measles Outbreaks in Canada
• ACS - 4, October 2013, Statement on Seasonal Influenza Vaccine for 2013-2014
  • Revised Wording to the National Advisory Committee on Immunization (NACI) Recommendation for Live Attenuated Influenza Vaccine (LAIV) in Healthy Children and Adolescents 2-17 Years of Age
• ACS - 5, November 2013, Statement on the Use of Conjugate Pneumococcal Vaccine - 13 Valent in Adults (Pneu-C-13),
• Volume 39-1, November 29, 2013, A synopsis of the Current evidence on the risk of HIV transmission
• Volume 39-1, November 29, 2013, A synopsis of the Human Immunodeficiency Virus (HIV) screening and testing guide
• Volume 39-2, December 13, 2013, Notes from the Deputy Chief Public Health Officer: The influenza season, A(H7N9) and MERS-CoV

Search CCDR